Clinical Trial Update: Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients

View source ↗

Summary

Results from a Korea post-marketing surveillance study of Xeljanz (tofacitinib) in Ulcerative Colitis patients have completed and results were posted in Septemb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• XELJANZ (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Ulcerative Colitis | Status: COMPLETED | Results posted: 2024-09-03